reviewNew England Journal of MedicineOct 1, 2008Closed access

Hepatitis B Virus Infection

Harvard University · Massachusetts General Hospital

PubMed
Indexed incrossrefpubmed

Abstract

More effective and less resistance-prone antiviral agents are now available to treat hepatitis B virus (HBV) infection. Profound, durable, therapeutic HBV DNA suppression to slow and reverse the progression of chronic HBV infection is important, given the evidence linking high-level HBV replication and the late consequences of chronic HBV infection. This article reviews strategies for treating HBV infection.

Citation impact

966
total citations
FWCI
43.97
Percentile
100%
References
129
Citations per year

Authors

1

Topics & keywords

Keywords
  • Medicine
  • Hepatitis B virus
  • Virology
  • Chronic infection
  • Virus
  • Chronic hepatitis
  • Hepatitis B
  • Immunology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.